Interventional Neurology Market Understand Trends Share Growth Overview and Forecast 2030
- mohit mrc
- Nov 30, 2022
- 2 min read
Interventional Neurology Market Insights:
In a recent research report by Market Research Community, the interventional neurology market is expected to surpass USD 3.85 Billion by the year 2030, from USD 2.46 Billion in 2021.
One of the subspecialties of neurology is interventional neurology. For the treatment of illnesses like intracranial atherosclerotic disease and cerebral aneurysms, surgical treatments like coil embolization, stenting, and others use catheters and radiography. Utilizing tools that can pass through blood vessels, interventional neurology helps diagnose disorders and lessens the need for open surgery.
In 2021, the flow diversion market is anticipated to expand significantly. During the projection period, it is anticipated that factors including enhanced endothelium regrowth, precise endoluminal repair, and a decreased requirement for medical intervention to treat aneurysms would boost the expansion of the flow diversion segment.
The market for interventional neurology is expected to rise at a faster rate during the projected period, with Asia-Pacific expected to provide the second-largest market share. The region's interventional neurology market is expanding as a result of factors like the expansion of the healthcare infrastructure, the rising prevalence of risk factors like diabetes, obesity, and hypertension that cause neurovascular diseases, particularly among the geriatric population, and the rising number of neurovascular incidents.
Despite a major decline in product sales during the early stages of the pandemic spread and global lockdown restrictions, the market is anticipated to rise at a high rate, reaching a CAGR of around 5.4% over the forecast period of 2022-2030.
The study is consolidated into major segments and further into sub-segments, such as by product type (aneurysm coiling devices and cerebral embolization (embolic coils, flow diversion devices, liquid embolic agents), neurothrombectomy devices, cerebral angioplasty and stenting systems, support devices), by disease pathology (arteriovenous malformation and fistulas, cerebral aneurysms, ischemic strokes, others (cavernous malformations and Moyamoya disease)), by technique (neurothrombectomy procedure, cerebral angiography technique, carotid endarterectomy (CEA), stenting, microsurgical clipping, coiling, flow diversion, and others), by end-use (hospitals & surgical centers, ambulatory care centers, research laboratories & academic institutes), to forecast the interventional neurology market size by value; also includes the analysis of past market dynamics from 2016 – 2021, considering 2021 as the base year.
The report also includes an analysis of each country and region, along with the most recent trends and major players like Abbott Laboratories, Johnson & Johnson, Boston Scientific Corporation, Stryker Corporation, Medtronic PLC, Terumo Corporation, Penumbra Inc., Microport Scientific Corporation, Merit Medical Systems Inc., W.L. Gore & Associates Inc., and B. Braun.
Contact:
Market Research Community
(UK) +44-20-8133-9198
Comments